FR2276317A1 - LACTAM-TYPE COMPOUNDS CONJUGATE WITH ANTIGENS FOR IMMUNOTIRATION OF CERTAIN MEDICINES - Google Patents
LACTAM-TYPE COMPOUNDS CONJUGATE WITH ANTIGENS FOR IMMUNOTIRATION OF CERTAIN MEDICINESInfo
- Publication number
- FR2276317A1 FR2276317A1 FR7512665A FR7512665A FR2276317A1 FR 2276317 A1 FR2276317 A1 FR 2276317A1 FR 7512665 A FR7512665 A FR 7512665A FR 7512665 A FR7512665 A FR 7512665A FR 2276317 A1 FR2276317 A1 FR 2276317A1
- Authority
- FR
- France
- Prior art keywords
- immunotiration
- lactam
- antigens
- type compounds
- certain medicines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9446—Antibacterials
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48402674A | 1974-06-28 | 1974-06-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2276317A1 true FR2276317A1 (en) | 1976-01-23 |
FR2276317B1 FR2276317B1 (en) | 1979-04-27 |
Family
ID=23922433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7512665A Granted FR2276317A1 (en) | 1974-06-28 | 1975-04-23 | LACTAM-TYPE COMPOUNDS CONJUGATE WITH ANTIGENS FOR IMMUNOTIRATION OF CERTAIN MEDICINES |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS511632A (en) |
CA (1) | CA1037475A (en) |
DE (1) | DE2521523A1 (en) |
FR (1) | FR2276317A1 (en) |
GB (1) | GB1511571A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0199963A1 (en) * | 1985-04-01 | 1986-11-05 | Abbott Laboratories | Ethosuximide assay tracers, immunogens and antibodies |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069105A (en) * | 1977-03-03 | 1978-01-17 | Syva Company | Lidocaine antigens and antibodies |
US4156081A (en) * | 1977-04-15 | 1979-05-22 | Syva Company | Theophylline antigens and antibodies |
IL68364A (en) * | 1982-06-01 | 1986-07-31 | Miles Lab | Ethosuximide immunogens,antibodies prepared therefrom and the use of such antibodies in immunoassays |
DE3924705A1 (en) * | 1989-07-26 | 1991-01-31 | Boehringer Mannheim Gmbh | HETEROBIFUNCTIONAL CONNECTIONS |
CN101863834B (en) * | 2010-06-29 | 2012-10-10 | 渤海大学 | Preparation method of S-carboxymethyl-5,5-diphenyl-2-thiohydantoin |
KR102267919B1 (en) | 2018-06-28 | 2021-06-23 | 주식회사 고영테크놀러지 | Method and electronic apparatus for determining cause of mounting failure for component mounted on board |
US11428644B2 (en) | 2018-11-27 | 2022-08-30 | Koh Young Technology Inc. | Method and electronic apparatus for displaying inspection result of board |
CN115372501B (en) * | 2022-07-27 | 2024-03-26 | 广州科曼生物科技有限公司 | Control extract of fritillaria thunbergii or fritillaria hubei, preparation method and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3817837A (en) * | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
-
1975
- 1975-04-02 GB GB1348875A patent/GB1511571A/en not_active Expired
- 1975-04-23 FR FR7512665A patent/FR2276317A1/en active Granted
- 1975-04-30 CA CA225,944A patent/CA1037475A/en not_active Expired
- 1975-05-14 DE DE19752521523 patent/DE2521523A1/en not_active Ceased
- 1975-05-22 JP JP6142475A patent/JPS511632A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0199963A1 (en) * | 1985-04-01 | 1986-11-05 | Abbott Laboratories | Ethosuximide assay tracers, immunogens and antibodies |
Also Published As
Publication number | Publication date |
---|---|
GB1511571A (en) | 1978-05-24 |
DE2521523A1 (en) | 1976-01-15 |
CA1037475A (en) | 1978-08-29 |
JPS638427B2 (en) | 1988-02-23 |
FR2276317B1 (en) | 1979-04-27 |
JPS511632A (en) | 1976-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ185846A (en) | Gamma globulin fractions substantially free of anticomplementary acitivity pharmaceutical compositions for intravenous administration | |
FR2314731A1 (en) | AZACYCLOALCAN-2-ONES 1-SUBSTITUTES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AS EXCIPIENTS | |
BE843140A (en) | AAZACYCLOALCAN-2-ONES 1-SUBSTITUTES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AS EXCIPIENTS | |
BE837579A (en) | COMPOSITIONS FOR ORAL HYGIENE | |
FR2341307A1 (en) | PYRETHRINOIDS FOR MEDICINAL PRODUCTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
FR2291638A1 (en) | TRIGGERABLE OSCILLATOR WITH PHASE-SLOWING MOUTH | |
DK360875A (en) | PROCEDURE FOR THE PREPARATION OF A PELLETED MEDICINE | |
BE787473A (en) | ASYMMETRICAL SYNTHESIS OF ALKYL CHRYSANTHEMATES | |
FR2312240A1 (en) | PROSTANE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT | |
FR2276317A1 (en) | LACTAM-TYPE COMPOUNDS CONJUGATE WITH ANTIGENS FOR IMMUNOTIRATION OF CERTAIN MEDICINES | |
FR2281376A1 (en) | SYNTHESIS OF DI-POLYOXYETHYLENE HYDROXYMETHYLPHOSPHONATE | |
DK90376A (en) | MEDICINE PACKAGING | |
BE842313A (en) | DEVICE USED TO MANUFACTURE TUBES OF THERMOPLASTIC SYNTHETIC MATERIAL PRESENTING LOW INTERNAL TENSIONS | |
FI55492C (en) | ANALOGIFICATION OF THE FRAMSTATION OF THE 2-AMINO-2 '6'-PROPIONOXYLIDES TO A PREPARATION AND ANTIARRYTIC EFFECT | |
BE826982A (en) | MEDICINAL PRODUCT FOR AVOIDING UEMIC SYMPTOMS AND ITS PREPARATION PROCEDURE | |
IL52433A0 (en) | A novel 2-phenylimino-imidazolidine derivative and salts thereof their preparation and pharmaceutical compositions containing them | |
FR2277577A1 (en) | PROSTANOIC ACID DERIVATIVES AND CONTAINING MEDICINAL PRODUCTS | |
FR2320298A1 (en) | PREPARATION OF OXERANE COMPOUNDS FROM MIXTURES CONTAINING HYDROXYESTERS | |
IL52547A0 (en) | A novel n-pyrrolidylmethyl-benzamide derivative and its salts their preparation and pharmaceutical compositions containing them | |
FR2283668A1 (en) | PROSTANOIC ACID DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT | |
BE757164A (en) | PREPARATION OF AMINES FROM ALCOHOLS | |
RO70080A (en) | PROCESS FOR PREPARATION OF N-ARYLSULFONYL-N '- (AZA-3-BICYLCOALCHYL) -ORES | |
FR2320949A1 (en) | PROCESS FOR PREPARING CYCLIC DIPHENYLSILOXANES, AND APPLICATION TO THE SYNTHESIS OF A METHYLPHENYLPOLYSILOXANE | |
FR2319605A1 (en) | PREPARATION OF ALKYLNAPHTHALEN MIXTURES | |
FR2286132A1 (en) | PREPARATION OF A 2-AMINOPYRROLINE DERIVATIVE |